BERLIN, Feb 1 Reuters German medical equipment maker Siemens Healthineers on Thursday posted firstquarter revenue above expectations and an operating result in line with consensus, driven by its U.S. cancer treatment unit Varian.

It said Varian39;s revenue improved most in China after sales had been affected by supply chain delays in the prioryear period.

Adjusted earnings before interest and taxes EBIT reached 742 million euros 802 million in the three months through December on revenue of 5.18 billion, the group said.

Analysts had expected quarterly adjusted EBIT of 742 million euros on revenue of 5.11 billion, according to a companyprovided poll.

The company39;s diagnostics unit, which encompasses its laboratory testing and includes the nowended COVID19test business, saw its quarterly revenue fall 7.7 in the first quarter.

Siemens Healthineers confirmed its 2024 guidance and still expects adjusted basic earnings per share to be between 2.10 and 2.30 euros and comparable revenue growth of between 4.5 to 6.5.

1 0.9257 euros

Reporting by Bartosz Dabrowski, editing by Kirsti Knolle

Source Reuters